FDA approved oral solid dosage (OSD) products are improving, changing and enhancing lives, via the use of a continuous manufacturing platform.
Read More
Solving biopharma design challenges with computational fluid dynamics
Computational fluid dynamics and cloud computing can make complex models more cost-effective and less time-consuming.
Read More
Passing through the barrier
Over the past decade, aseptic filling isolators have improved patient safety by use of barriers to isolate the point of filling from personnel. This industry-wide movement creates opportunities to further increase patient safety by minimizing viable and nonviable risks to the aseptic fill.
Read More
Strip the strip curtains in aseptic cleanrooms
Like most things, improvement happens naturally over time with the application of knowledge and the advancement of technology. This is particularly true for aseptic cleanrooms and even more so with respect to strip curtains. As cleanroom technology has evolved, we’ve developed a better understanding of how to—and how not to—maintain an aseptic environment.
Read More
How to choose a contract manufacturing organization
The age-old debate of whether to outsource production to a contract manufacturing organization (CMO) remains for mature, emerging and virtual biopharmaceutical companies.
Read More
Designing an OSD facility to protect drug products
Protecting OSD drug products from contamination during manufacturing is vitally important. Here’s how facility design can help. *As appeared in Tablets & Capsules – Solid Dose Digest, July 10, 2017
Read More
Building a thoughtful manufacturing supply chain
In the past 5 years, the biopharmaceutical industry has seen unprecedented change. Precipitated by the need to support a global client base with products that are more targeted, efficacious and cost-effective, the challenge to have a robust manufacturing supply chain is more crucial than ever to a company’s survival.
Read More